Oncologianova GmbH

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Gastric and oesophageal cancer1 trial
• Metastatic breast cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 31 trial

Status

• Active, not recruiting2 trials
• Terminated1 trial

Lead sponsor

• Bristol-Myers Squibb1 trial
• GBG Forschungs GmbH1 trial
• Pfizer1 trial

Running trials

• Active, not recruiting

  Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

  NCT04595565· Phase 3· GBG Forschungs GmbH· Source

• Active, not recruiting

  First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.

  NCT04767594· Pfizer· Source

Closed trials

• Terminated

  A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer

  NCT05780736· Bristol-Myers Squibb· Source